Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 17, 2020 | Chief Legal Officer | Other acquisition or disposition | Form 4 | -- | -- | 15,000 | |
| Jan 15, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 20,720 | $10.35 | 156,473 | |
| Jan 15, 2020 | Director, Chief Operating Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 5,064 | $10.35 | 370,520 | |
| Jan 15, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | $5.13 | 1,058,339 | |
| Jan 15, 2020 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 100,000 | $10.35 | 958,339 | |
| Jan 15, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | -- | 202,485 | |
| Jan 15, 2020 | Chief Legal Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 22,100 | $10.35 | 185,350 | |
| Jan 14, 2020 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 | |
| Jan 14, 2020 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Jan 14, 2020 | Chief Legal Officer | Other acquisition or disposition | Form 4 | -- | -- | 15,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.